| 07/13/2026 7:30 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 3:13 PM | Johnson-Greene Treerita Essalima (2113708) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:30 PM | Coleman Blaise (1689280) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:31 PM | Ocugen (1372299) Issuer Zhang Junge (1790205) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:32 PM | Castillo Kirsten (1808806) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:33 PM | Chandrasekhar Satishchandran (1832285) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:35 PM | Kompella Uday (1791821) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 4:19 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 3:30 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 3:31 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 10:37 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for OCGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ocugen and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/04/2026 3:03 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 6:00 AM | Ocugen (1372299) Filer | Form DEF 14A | |
| 04/28/2026 6:01 AM | Ocugen (1372299) Filer | Form ARS | |
| 04/28/2026 6:01 AM | Ocugen (1372299) Filer | Form DEFA14A | |
| 04/20/2026 4:18 PM | Ocugen (1372299) Filer | Form PRER14A | |
| 04/17/2026 3:56 PM | Ocugen (1372299) Filer | Form PRE 14A | |
| 04/14/2026 5:38 PM | MILLENNIUM MANAGEMENT LLC (1273087) Filed by Ocugen (1372299) Subject | Form SCHEDULE 13G | |
| 04/02/2026 8:26 PM | Ocugen (1372299) Issuer Zhang Junge (1790205) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 11:02 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:00 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/05/2026 8:27 AM | Johnson-Greene Treerita Essalima (2113708) Reporting Ocugen (1372299) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/04/2026 11:23 AM | Ocugen (1372299) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/04/2026 10:07 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 10:12 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 10:38 AM | Ocugen (1372299) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/09/2026 6:59 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 7:12 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/21/2026 4:27 PM | Ocugen (1372299) Filer | Form 424B5 | |
| 01/21/2026 4:29 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/15/2026 7:31 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 4:20 PM | Ocugen (1372299) Issuer Ramachandran Ramesh (2043659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 4:20 PM | Musunuri Shankar (1791820) Reporting Ocugen (1372299) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:17 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 10:45 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Ocugen (1372299) Subject | Form SCHEDULE 13G | |
| 11/05/2025 8:41 AM | Ocugen (1372299) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 6:30 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/31/2025 10:03 AM | Ocugen (1372299) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 09/18/2025 10:00 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 3:11 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2025 7:35 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
BSEM Announces Major Corporate Milestone (Ad) BioStem Technologies (OTC: BSEM) has publicly filed a Form 10 registration statement with the SEC, advancing its progress toward a planned Nasdaq uplisting.
CEO Jason Matuszewski says the filing is expected to enhance credibility, expand capital access, and improve market visibility. BioStem is a regenerative medicine company commercializing perinatal tissue allograft products via its proprietary BioRetain, CryoTek, and SteriTek processing technologies. Read the full press release to learn what comes next for BSEM |
| 08/11/2025 7:30 AM | Ocugen (1372299) Filer | Form 424B5 | |
| 08/04/2025 7:29 AM | Ocugen (1372299) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/01/2025 11:23 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2025 3:36 PM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2025 5:30 AM | Ocugen (1372299) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2025 6:54 PM | BlackRock, Inc. (2012383) Filed by Ocugen (1372299) Subject | Form SCHEDULE 13G/A | |